FDA approves Nektar's OMONTYS to treat CKD-related anemia
 

Nektar Therapeutics today reported that its partner Affymax, Inc. announced that the U.S. Food and Drug Administration (FDA) has approved OMONTYS (peginesatide) Injection for the treatment of anemia due to chronic kidney disease (CKD) in adult patients on dialysis.

More...